Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Cutting-edge editing techniques are accelerating efforts to create high-yield, resilient varieties of major agricultural products.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.